A post hoc pooled analysis to evaluate hypoglycaemia risk with insulin glargine 300 U/mL (Gla ‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in people with type 2 diabetes on a basal‐only insulin regimen
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 30, 2018 Category: Endocrinology Authors: Geremia B.
Bolli
MD
,
Carol
Wysham
MD
,
Miles
Fisher
MD
,
Soazig
Chevalier
MS
,
Anna MG
Cali
MD
,
Bruno
Leroy
MD
,
Matthew C.
Riddle
MD Source Type: research
Association of Abdominal Muscle Composition with Prediabetes and Diabetes: The CARDIA Study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 30, 2018 Category: Endocrinology Authors: Andrea
Granados
MD
,
Achamyeleh
Gebremariam
MS
,
Samuel S.
Gidding
MD
,
James G.
Terry
MS
,
J. Jeffrey
Carr
MD, MSc
,
Lyn M.
Steffen
PhD,MPH, RD
,
David R.
Jacobs
Jr, PhD
,
Joyce M.
Lee
MD, MPH Source Type: research
Intensive multidisciplinary weight management in patients with type 1 diabetes and obesity: A one ‐year retrospective matched cohort study
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 30, 2018 Category: Endocrinology Authors: Adham
Mottalib
MD
,
Shaheen
Tomah
MD
,
Samar
Hafida
MD
,
Taha
Elseaidy
BS
,
Megan
Kasetty
BS
,
Sahar
Ashrafzadeh
AB
,
Osama
Hamdy
MD Source Type: research
Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild ‐to‐moderate renal impairment
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 30, 2018 Category: Endocrinology Authors: F.
Javier Escalada
MD
,
Serge
Halimi
MD
,
Peter A.
Senior
PhD
,
Mireille
Bonnemaire
MD
,
Anna M. G.
Cali
MD
,
Lydie
Melas ‐Melt
MSc
,
Janaka
Karalliedde
PhD
,
Robert A.
Ritzel
MD Source Type: research
Mechanistic Insights From Sequential Combination Therapy With An SGLT2 Inhibitor and DPP ‐IV Inhibitor: Results From the CANARIS Trial using Canagliflozin and Teneligliptin
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 27, 2018 Category: Endocrinology Authors: Sumie
Okahata
MD, PhD
,
Kentaro
Sakamoto
MD, PhD
,
Takako
Mitsumatsu
MD, PhD
,
Yuko
Kondo
MD
,
Shoji
Tanaka
MD
,
Teruo
Shiba
MD Source Type: research
Changes in Arginine are Inversely Associated with Type 2 Diabetes: A Case ‐Cohort Study in the PREDIMED Trial
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 27, 2018 Category: Endocrinology Authors: Edward
Yu
,
Miguel
Ruiz ‐Canela
,
Cristina
Razquin
,
Marta
Guasch‐Ferre
,
Estefania
Toledo
,
Dong D.
Wang
,
Christopher
Papandreou
,
Courtney
Dennis
,
Clary
Clish
,
Liming
Liang
,
Monica
Bullo
,
Dolores
Co Source Type: research
Atrial fibrillation and type 2 diabetes: prevalence, etiology, pathophysiology and effect of anti ‐diabetic therapies
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 25, 2018 Category: Endocrinology Authors: David S. H.
Bell
MB
,
Edison
Goncalves
MD Source Type: research
Meta ‐analysis of the association between sodium‐glucose co‐transporter‐2 inhibitors and risk of skin cancer among patients with type 2 diabetes
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 24, 2018 Category: Endocrinology Authors: Huilin
Tang
MSc
,
Keming
Yang
MD
,
Yiqing
Song
MD
,
Jiali
Han
PhD Source Type: research
Impact on HbA1c and body weight of switching from other GLP ‐1 receptor agonists to semaglutide: A model‐based approach
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 24, 2018 Category: Endocrinology Authors: Rune V.
Overgaard
PhD
,
S øren Ø.
Lindberg
MD
,
Desirée
Thielke
MD Source Type: research
Real ‐World Opportunity of Empagliflozin to Improve Blood Pressure Control in African Americans with Type 2 Diabetes: An NCDR® “Research‐to‐Practice” Project From the Diabetes Collaborative Registry (DCR)
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 23, 2018 Category: Endocrinology Authors: Suzanne V.
Arnold
MD MHA
,
Leo
Seman
MD PhD
,
Fengming
Tang
MS
,
Poghni A.
Peri ‐okonny
MD
,
Keith C.
Ferdinand
MD
,
Sanjeev N.
Mehta
MD MPH
,
Abhinav
Goyal
MD MHS
,
Laurence S.
Sperling
MD
,
Mikhail
Kosiborod
MD Source Type: research
Comment on Ryan, et al. Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non ‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real‐world meta‐analysis of 4 observational databases (OBSERVE‐4D). Diabetes Obes Metab. 2018; doi: 10.1111/dom.13424.
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 23, 2018 Category: Endocrinology Authors: Patrick B.
Ryan
,
Norm
Rosenthal Source Type: research
Management of patients with diabetes and heart failure with reduced ejection fraction: an international comparison
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 23, 2018 Category: Endocrinology Authors: Suzanne V.
Arnold
MD MHA
,
Jonathan
Yap
MD
,
Carolyn S.P.
Lam
MBBS PhD
,
Fengming
Tang
MS
,
Wan T.
Tay
PhD
,
Tiew H.K.
Teng
PhD
,
Darren K.
McGuire
MD MHSc
,
James L.
Januzzi
MD
,
Gregg C.
Fonarow
MD
,
Frederick A.
Mas Source Type: research
Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world. A multicentre retrospective study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 23, 2018 Category: Endocrinology Authors: Gian Paolo
Fadini
,
Anna
Solini
,
Maria Laura
Manca
,
Giuseppe
Penno
,
Adriano
Gatti
,
Roberto
Anichini
,
Stefano
Del Prato
,
Angelo
Avogaro
, Source Type: research
Genetic Polymorphisms of the Endocannabinoid System in Obesity and Diabetes
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 21, 2018 Category: Endocrinology Authors: Joe
Doris
,
Sophie A.
Millar
,
Iskandar
Idris
,
Saoirse E.
O'Sullivan Source Type: research
Efficacy and Safety of Once ‐weekly Dulaglutide Versus Insulin Glargine in Mainly Asian Patients with Type 2 Diabetes Mellitus on Metformin and/or a Sulfonylurea: a 52‐week Open‐label, Randomized Phase 3 Trial
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 21, 2018 Category: Endocrinology Authors: Weiqing
Wang
MD
,
Luis Nevarez
Ruiz
MD
,
Ekaterina
Filippova
MD
,
Ki Ho
Song
MD
,
Bei
Tao
MD
,
Liqun
Gu
MD
,
Feng
Wang
MD
,
Pengfei
Li
PhD
,
Jun
Yang
MD Source Type: research